Update on pre-diabetes: Focus on diagnostic criteria and cardiovascular risk

Figure 1 Agreement between glycated haemoglobin pre-diabetes, impaired fasting glucose and impaired glucose tolerance[2]. IFG: Impaired fasting glucose; IGT: Impaired glucose tolerance; HbA1c: Glycated haemoglobin.

Figure 2 Intima media thickness, endogenous receptor for advanced glycation end-products, S100A12 and 5-hydroxyvitamin D according to glucose tolerance and glycated haemoglobin levels. A: IMT, ^aP < 0.05 vs CTRL; B: esRAGE, ^aP < 0.05 vs CTRL; C: S100A12, ^aP < 0.05 vs CTRL; D: 25(OH)D, ^aP < 0.05 vs CTRL. IMT: Intima-media thickness; esRAGE: Endogenous receptor for advanced glycation end-products; 25(OH)D: 25-hydroxyvitamin D; NFG: Normal fasting glucose; NGT: Normal glucose tolerance; IFG: Impaired fasting glucose; IGT: Impaired glucose tolerance; T2DM: Type 2 diabetes mellitus; HbA_1c: Glycated haemoglobin.